We are live on ! Find out more
GNMK

GenMark Diagnostics, Inc
GNMK

Delisted

GNMK was delisted on the 21st of April, 2021.

Back to rankings

78 hedge funds and large institutions have $516M invested in GenMark Diagnostics, Inc in 2013 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 35 increasing their positions, 19 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

84% more repeat investments, than reductions

Existing positions increased: 35 | Existing positions reduced: 19

63% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 8

9% more capital invested

Capital invested by funds: $474M → $516M (+$42M)

7% more funds holding

Funds holding: 73 → 78 (+5)

18% less call options, than puts

Call options by funds: $9K | Put options by funds: $11K

Holders
78
Holders Change
+5
Holders Change %
+6.85%
% of All Funds
2.26%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
35
Reduced
19
Closed
8
Calls
$9K
Puts
$11K
Net Calls
-$2K
Net Calls Change
+$18K

Top Buyers

Rank Fund Capital Flow
1
JP Morgan Chase
JP Morgan Chase
New York
+$5.62M
2
PI
Putnam Investments
Massachusetts
+$4.42M
3
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$3.94M
4
CCM
Cadian Capital Management
New York
+$3.89M
5
Ameriprise
Ameriprise
Minnesota
+$3.29M

Top Sellers

Rank Fund Capital Flow
1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$18.9M
2
PHS
PFM Health Sciences
California
-$7.89M
3
Citadel Advisors
Citadel Advisors
Florida
-$5.11M
4
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$3.14M
5
Artisan Partners
Artisan Partners
Wisconsin
-$2.15M
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$82.8M +$2.05M +168,881 +3%
PI
2
Putnam Investments
Massachusetts
$69.3M +$4.42M +363,627 +8%
Jennison Associates
3
Jennison Associates
New York
$54.7M -$1.37M -112,946 -3%
T. Rowe Price Associates
4
T. Rowe Price Associates
Maryland
$35.3M -$18.9M -1,558,500 -37%
JP Morgan Chase
5
JP Morgan Chase
New York
$33.9M +$5.62M +462,403 +22%
Artisan Partners
6
Artisan Partners
Wisconsin
$30.6M -$2.15M -177,313 -7%
Massachusetts Financial Services
7
Massachusetts Financial Services
Massachusetts
$24.9M -$137K -11,280 -0.6%
Adage Capital Partners
8
Adage Capital Partners
Massachusetts
$21.5M +$3.94M +324,671 +25%
BFA
9
BlackRock Fund Advisors
California
$12.9M -$496K -40,843 -4%
CRC
10
Curi RMB Capital
Illinois
$12.7M -$524K -43,116 -4%
CCM
11
Camber Capital Management
Massachusetts
$12.6M – – –
VAM
12
Visium Asset Management
New York
$12.2M +$1.66M +136,767 +18%
Vanguard Group
13
Vanguard Group
Pennsylvania
$12M +$273K +22,510 +3%
Bank of America
14
Bank of America
North Carolina
$10.5M -$6.29K -518 -0.1%
CCM
15
Cadian Capital Management
New York
$10.3M +$3.89M +320,000 +70%
State Street
16
State Street
Massachusetts
$6.81M +$1.33M +109,412 +27%
Northern Trust
17
Northern Trust
Illinois
$6.8M +$270K +22,214 +5%
JHIU
18
Janus Henderson Investors US
Colorado
$5.68M -$63.1K -5,193 -1%
BIT
19
BlackRock Institutional Trust
California
$5.45M -$296K -24,407 -6%
PC
20
PointState Capital
New York
$3.97M – – –
Schroder Investment Management Group
21
Schroder Investment Management Group
United Kingdom
$3.93M -$353K -29,100 -9%
Ameriprise
22
Ameriprise
Minnesota
$3.64M +$3.29M +271,304 +12,133%
Alyeska Investment Group
23
Alyeska Investment Group
Illinois
$3.36M -$3.14M -258,606 -51%
MACM
24
March Altus Capital Management
Connecticut
$2.98M +$2.72M +223,818 New
Bank of New York Mellon
25
Bank of New York Mellon
New York
$2.73M +$755K +62,204 +43%
1
2 3 4

GNMK Hedge Fund Activity: Q4 2013 in Review

78 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in GenMark Diagnostics, Inc (GNMK) for Q4 2013, worth a combined $516M — up 8.9% from $474M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new GNMK positions and 8 closed out — a net gain of 5 holders — while 35 added to existing stakes and 19 trimmed.

The largest buyer was JP Morgan Chase, adding an estimated $5.62M. The largest seller was T. Rowe Price Associates, cutting an estimated $18.9M.

  • 78 institutional investors held GenMark Diagnostics, Inc (GNMK) as of Q4 2013, up from 73 in Q3 2013.
  • Funds reported $516M of GenMark Diagnostics, Inc stock for Q4 2013, up 8.9% quarter-over-quarter.
  • 13 funds opened new GenMark Diagnostics, Inc positions in Q4 2013 and 8 closed out, a net change of +5 holders.
  • The largest GenMark Diagnostics, Inc buyer in Q4 2013 was JP Morgan Chase, an estimated $5.62M added.
  • The largest GenMark Diagnostics, Inc seller in Q4 2013 was T. Rowe Price Associates, an estimated $18.9M sold.

Based on aggregated 13F filings for Q4 2013.